Rates of colorectal cancer screening via CT colonography are higher when patients have health insurance policies that cover the screening.
Patients are more likely to undergo CT colonography for colorectal cancer (CRC) screening if their insurance policies cover the testing, according to a study published in Radiology.
Researchers from the University of Wisconsin-Madison School of Medicine and Public Health, performed a retrospective cohort study to compare overall CRC screening rates for patients who were eligible and due for CRC screening and who were with and without insurance coverage for CT colonography for CRC screening. “CT colonography is a newer technology that can detect both pre-cancer and cancer, but because it’s relatively new it isn’t widely covered by insurance and isn’t covered by Medicare,” lead author Maureen A. Smith, MD, PhD, MPH, said in a release.[[{"type":"media","view_mode":"media_crop","fid":"61761","attributes":{"alt":"Maureen A. Smith, MD, PhD, MPH","class":"media-image media-image-right","id":"media_crop_4296953263489","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"7814","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":"Maureen A. Smith, MD, PhD, MPH","typeof":"foaf:Image"}}]]
The researchers evaluated data from 33,177 patients, aged 64 or younger, who were eligible and due for CRC screening. The results showed that after adjustment, those patients whose insurance policies covered CT colonography who were due for CRC screening had a 48% higher likelihood of undergoing screening by any method, compared with those who did not have similar insurance coverage. In addition, the patients with CT colonography coverage had a greater likelihood of being screened with CT colonography and with colonoscopy, but not with fecal occult blood test than those without such insurance coverage.
“Our study suggests that when people are offered a greater choice of screening tests for colorectal cancer, including CT colonography, they are more likely to complete screening to prevent colorectal cancer,” Smith said in the release. “Policymakers should consider additional options for screening and prevention of colorectal cancer. CT colonography is potentially a powerful option, because there are people who will prefer it.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.